You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 23, 2025

Details for Patent: 12,146,003


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 12,146,003
Title:Ultra-pure agonists of guanylate cyclase C, method of making and using same
Abstract:The invention provides processes of purifying a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-251 described herein. The processes include a solvent exchange step before a freeze-drying (lyophilization) step.
Inventor(s):Kunwar Shailubhai, Stephen Comiskey, Rong Feng, Juncai BAI, Ruoping ZHANG, Jun Jia, Junfeng Zhou, Qiao Zhao, Guoqing Zhang
Assignee:Bausch Health Ireland Ltd
Application Number:US18/511,852
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 12,146,003: A Comprehensive Guide

Introduction

When delving into the world of patents, understanding the scope and claims of a specific patent is crucial for inventors, businesses, and legal professionals. This article will provide a detailed analysis of the scope and claims of United States Patent 12,146,003, using general principles and best practices in patent analytics.

Understanding Patent Claims

What are Patent Claims?

Patent claims are the most critical part of a patent application, as they define the scope of the invention and what is protected by the patent. These claims must be clear, concise, and supported by the patent's description and drawings[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a device or system.

Analyzing the Scope of a Patent

Claim Coverage Matrix

To analyze the scope of a patent like US Patent 12,146,003, a Claim Coverage Matrix is often used. This matrix helps identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. It categorizes patents not only by claims but also by overarching scope concepts that link claims on similar patents[3].

Scope Concepts

Scope concepts are powerful categorization tools for filtering, searching, and accurately analyzing large numbers of patent claims. These concepts can be high-value, indicating immediate relevance to the company; medium-value, suggesting potential future directions; or low-value, indicating claims that may not be worth maintaining[3].

Patent Landscape Analysis

Tracking Patents by Claims and Scope Concepts

Patent landscape analysis involves tracking patents by their claims and scope concepts. This helps in understanding the broader intellectual property landscape and identifying areas where the patent in question fits in. For example, using software like ClaimScape®, all claims and associated scope concepts can be stored and analyzed to determine their applicability to target products or methods[3].

Interactive Claim Charts

Interactive claim charts generated by software tools can be reviewed by technical experts to determine whether a particular scope concept is applicable to a target product or method. These charts are quick, accurate, and help in identifying gaps in current coverage and highlighting future design opportunities[3].

Legal and Regulatory Considerations

Patent Term and Examination

The term of a U.S. patent is 20 years from the effective filing date, a change introduced by the Uruguay Round Agreements Act (URAA) to promote timely disclosure of innovations. This change affected the incentives for patent applicants and the examination process. For instance, the URAA addressed transitional applications and the need for reexamination of certain pending applications[2].

Patent Quality and Examination Time

The U.S. Patent and Trademark Office (USPTO) has been recommended to define patent quality more consistently and reassess the time allotted for examination. This includes analyzing the effects of incentives on patent quality and considering additional clarity tools for applicants. The USPTO has implemented measures such as correctness measures and quantifiable compliance targets to improve patent quality[4].

Global Patenting Trends

Time, Technology, and Country

Analyzing global patenting trends involves considering time, technology, and country elements. For example, the publication year of PCT applications and the technology categories based on IPCs (International Patent Classification) are crucial. The country assigned to a PCT application is typically based on the receiving office, which in most cases is the national patent office where the inventors reside[1].

Gender and Inventorship Analysis

Fractional Counting

In analyzing patent data, fractional counting is used to allocate patents to countries based on the inventor locations listed on the earliest patent document in the family. This method also helps in gender analysis, where the total count of patents for each given name is calculated to determine the gender distribution among inventors. However, this method may leave some names unmatched due to ambiguity or unusual names[1].

Small Claims Patent Court

Feasibility and Structure

There has been a study on the feasibility and potential structure of a small claims patent court in the U.S. This study, conducted by the Administrative Conference of the United States (ACUS), considered the need for such a court, its potential structure, and relevant legal, policy, and practical considerations. Public comments and stakeholder input were crucial in this study[5].

Key Takeaways

  • Clear Claims: Patent claims must be clear and concise to define the scope of the invention effectively.
  • Scope Concepts: Analyzing patents by scope concepts helps in understanding the broader intellectual property landscape.
  • Legal Considerations: Understanding changes in patent law, such as those introduced by the URAA, is essential for managing patent applications.
  • Global Trends: Analyzing global patenting trends involves considering time, technology, and country elements.
  • Patent Quality: Defining and ensuring patent quality is a continuous process for the USPTO.

FAQs

What is the purpose of a Claim Coverage Matrix in patent analytics?

A Claim Coverage Matrix helps identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. It categorizes patents by claims and overarching scope concepts.

How has the URAA affected patent terms in the United States?

The URAA changed the patent term from 17 years from the grant date to 20 years from the effective filing date to promote timely disclosure of innovations.

What is fractional counting in patent analysis?

Fractional counting is a method used to allocate patents to countries based on the inventor locations listed on the earliest patent document in the family. It also helps in gender analysis among inventors.

Why is defining patent quality important for the USPTO?

Defining patent quality is important for ensuring that patents meet statutory compliance rates and for maintaining the integrity of the patent system. It involves correctness measures and quantifiable compliance targets.

What is the significance of a small claims patent court study?

The study on a small claims patent court aims to determine the feasibility and potential structure of such a court, addressing legal, policy, and practical considerations to make patent litigation more accessible and efficient for smaller entities.

Sources

  1. National Science Foundation, "Invention, Knowledge Transfer, and Innovation," Science and Engineering Indicators 2024: Technical Documentation, February 29, 2024.
  2. United States Court of Appeals for the Federal Circuit, "HYATT v. PTO," September 8, 2022.
  3. Schwegman Lundberg & Woessner, P.A., "Patent Analytics," SLWIP.
  4. Government Accountability Office, "Intellectual Property: Patent Office Should Define Quality, Reassess Time Allotted for Examination," June 30, 2016.
  5. Administrative Conference of the United States, "U.S. Patent Small Claims Court," ACUS.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 12,146,003

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Salix TRULANCE plecanatide TABLET;ORAL 208745-001 Jan 19, 2017 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 12,146,003

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2014274812 ⤷  Try for Free
Australia 2018226473 ⤷  Try for Free
Australia 2020205349 ⤷  Try for Free
Brazil 112015030326 ⤷  Try for Free
Canada 2913737 ⤷  Try for Free
China 105764916 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.